Dr. Rehman Ukani, MD

Dr. Ukani practices at Skagit Valley Hospital in Mount Vernon, Washington, part of Skagit Regional Health.

Dr. Ukani's NPI, 1700272564, was assigned on April 8, 2015. Dr. Ukani holds Washington license MD61318600.

Dr. Ukani's primary practice is Skagit Valley Hospital, at 1415 Kincaid Street, Mount Vernon, WA 98274 in Skagit County. The practice phone is (360) 424-4111.

Dr. Ukani's primary practice is Skagit Valley Hospital in Mount Vernon, Washington, part of Skagit Regional Health. Dr. Ukani is also affiliated with WhidbeyHealth Medical Center. The medical group on file is Skagit Regional Clinics. Dmand AI also links Dr. Ukani to 1 more hospital and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ukani practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Ukani's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Ukani's licenses on file in 2 states: Washington and Indiana.

CMS data shows 475 Medicare services from Dr. Ukani across 5 procedure codes in 2024, for 133 Medicare patients. Medicare paid $41,171 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Dr. Ukani in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ukani's median patient age at 70, with 49% women.

In 2024, Dr. Ukani wrote 123 Medicare Part D claims for 38 patients. 87% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $3,112 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Ukani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ukani as offering telehealth.

Dmand AI links 7 papers to Dr. Ukani, published from 2010 to 2018. 2011 was the busiest year, with 3. The most frequent topics are Quinolines, Lactalbumin and Structure-Activity Relationship. Dr. Ukani has published most often in Bioorg Med Chem Lett. Dr. Ukani's most frequent co-authors are Badar Mumtaz Hasan, MD, Rebecca R. Pauly, MD and Zafar Ali, MD.

CMS Open Payments shows 12 general payments to Dr. Ukani from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $218.